世界における感染症迅速/POC検査製品のパイプライン動向2015...市場調査レポートについてご紹介

【英文タイトル】Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Review, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 13
2 Introduction 14
2.1 Infectious Diagnostics Rapid & Point of Care Tests Overview 14
3 Products under Development 15
3.1 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Stage of Development 15
3.2 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Segment 16
3.3 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Territory 17
3.4 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Regulatory Path 19
3.5 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Estimated Approval Date 20
4 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products under Development by Companies 21
4.1 Infectious Diagnostics Rapid & Point of Care Tests Companies – Pipeline Products by Stage of Development 21
4.2 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Stage of Development 24
5 Infectious Diagnostics Rapid & Point of Care Tests Companies and Product Overview 29
5.1 A&B Professional di Barsali Brunella Company Overview 29
5.1.1 A&B Professional di Barsali Brunella Pipeline Products & Ongoing Clinical Trials Overview 29
5.2 Akers Biosciences, Inc. Company Overview 30
5.2.1 Akers Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.3 Analyticon Biotechnologies AG Company Overview 34
5.3.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 34
5.4 Aseptika Ltd Company Overview 36
5.4.1 Aseptika Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
5.5 Atomo Diagnostics Pty Limited Company Overview 37
5.5.1 Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 37
5.6 Autoimmune Technologies, LLC Company Overview 39
5.6.1 Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 39
5.7 BACTERIOSCAN LTD. Company Overview 40
5.7.1 BACTERIOSCAN LTD. Pipeline Products & Ongoing Clinical Trials Overview 40
5.8 Biocartis SA Company Overview 41
5.8.1 Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview 41
5.9 BioFire Diagnostics, Inc. Company Overview 42
5.9.1 BioFire Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.10 Biotech Consortium India Limited Company Overview 43
5.10.1 Biotech Consortium India Limited Pipeline Products & Ongoing Clinical Trials Overview 43
5.11 Calypte Biomedical Corporation Company Overview 47
5.11.1 Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview 47
5.12 Canon U.S.A., Inc. Company Overview 50
5.12.1 Canon U.S.A., Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.13 Cepheid Company Overview 51
5.13.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 51
5.14 Coris BioConcept Company Overview 63
5.14.1 Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview 63
5.15 Denka Seiken Co., Ltd. Company Overview 64
5.15.1 Denka Seiken Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 64
5.16 Diagnostics for the Real World (Europe) Ltd. Company Overview 65
5.16.1 Diagnostics for the Real World (Europe) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 65
5.17 DIESSE Diagnostica Senese S.p.A. Company Overview 66
5.17.1 DIESSE Diagnostica Senese S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 66
5.18 First Light Biosciences, Inc. Company Overview 67
5.18.1 First Light Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.19 Foundation for Innovative New Diagnostics Company Overview 68
5.19.1 Foundation for Innovative New Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 68
5.20 Genalyte, Inc. Company Overview 76
5.20.1 Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
5.21 GeneFluidics Inc. Company Overview 77
5.21.1 GeneFluidics Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.22 Great Basin Corporation Company Overview 79
5.22.1 Great Basin Corporation Pipeline Products & Ongoing Clinical Trials Overview 79
5.23 Hema Diagnostic Systems, LLC Company Overview 80
5.23.1 Hema Diagnostic Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 80
5.24 Immunexpress Pty Ltd Company Overview 81
5.24.1 Immunexpress Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 81
5.25 ImmunoScience, Inc. Company Overview 82
5.25.1 ImmunoScience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
5.26 InBios International, Inc. Company Overview 88
5.26.1 InBios International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
5.27 Infectious Disease Research Institute Company Overview 91
5.27.1 Infectious Disease Research Institute Pipeline Products & Ongoing Clinical Trials Overview 91
5.28 Innova Biotechnology Co., Ltd. Company Overview 92
5.28.1 Innova Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 92
5.29 Insilixa, Inc. Company Overview 96
5.29.1 Insilixa, Inc. Pipeline Products & Ongoing Clinical Trials Overview 96
5.30 Institut de Recherche pour le Developpement Company Overview 98
5.30.1 Institut de Recherche pour le Developpement Pipeline Products & Ongoing Clinical Trials Overview 98
5.31 Institut Pasteur Company Overview 101
5.31.1 Institut Pasteur Pipeline Products & Ongoing Clinical Trials Overview 101
5.32 Integrated DNA Technologies, Inc. Company Overview 102
5.32.1 Integrated DNA Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 102
5.33 James Cook University Company Overview 103
5.33.1 James Cook University Pipeline Products & Ongoing Clinical Trials Overview 103
5.34 Labsystems Diagnostics Oy Company Overview 104
5.34.1 Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview 104
5.35 Leiden University Company Overview 107
5.35.1 Leiden University Pipeline Products & Ongoing Clinical Trials Overview 107
5.36 Life Technologies Corporation Company Overview 108
5.36.1 Life Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 108
5.37 Lucigen Corporation Company Overview 109
5.37.1 Lucigen Corporation Pipeline Products & Ongoing Clinical Trials Overview 109
5.38 Meru University of Science & Technology Company Overview 110
5.38.1 Meru University of Science & Technology Pipeline Products & Ongoing Clinical Trials Overview 110
5.39 Micronics, Inc. (of Sony Group) Company Overview 111
5.39.1 Micronics, Inc. (of Sony Group) Pipeline Products & Ongoing Clinical Trials Overview 111
5.40 NexGen Arrays Company Overview 116
5.40.1 NexGen Arrays Pipeline Products & Ongoing Clinical Trials Overview 116
5.41 NOWDiagnostics Company Overview 117
5.41.1 NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 117
5.42 OptiCul Diagnostics Ltd. Company Overview 132
5.42.1 OptiCul Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 132
5.43 PrimerDesign Limited Company Overview 133
5.43.1 PrimerDesign Limited Pipeline Products & Ongoing Clinical Trials Overview 133
5.44 Protein Advances Inc. Company Overview 134
5.44.1 Protein Advances Inc. Pipeline Products & Ongoing Clinical Trials Overview 134
5.45 Quidel Corporation Company Overview 136
5.45.1 Quidel Corporation Pipeline Products & Ongoing Clinical Trials Overview 136
5.46 Quotient Limited Company Overview 140
5.46.1 Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview 140
5.47 Randox Laboratories Limited Company Overview 142
5.47.1 Randox Laboratories Limited Pipeline Products & Ongoing Clinical Trials Overview 142
5.48 Rockefeller University Company Overview 143
5.48.1 Rockefeller University Pipeline Products & Ongoing Clinical Trials Overview 143
5.49 Sedia Biosciences Corporation Company Overview 144
5.49.1 Sedia Biosciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 144
5.50 Sight Diagnostics Ltd. Company Overview 145
5.50.1 Sight Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 145
5.51 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 146
5.51.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 146
5.52 Standard Diagnostics, Inc. Company Overview 147
5.52.1 Standard Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 147
5.53 The Johns Hopkins University Company Overview 149
5.53.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 149
5.54 U.S. Army Medical Research Institute of Infectious Diseases Company Overview 151
5.54.1 U.S. Army Medical Research Institute of Infectious Diseases Pipeline Products & Ongoing Clinical Trials Overview 151
5.55 University of California, Berkeley Company Overview 152
5.55.1 University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview 152
5.56 University of California, Irvine Company Overview 154
5.56.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 154
5.57 University of Edinburgh Company Overview 156
5.57.1 University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 156
5.58 University of Nevada, Reno Company Overview 157
5.58.1 University of Nevada, Reno Pipeline Products & Ongoing Clinical Trials Overview 157
5.59 University of Oxford Company Overview 163
5.59.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 163
5.60 University of Virginia Company Overview 164
5.60.1 University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 164
5.61 Vircell S.L Company Overview 165
5.61.1 Vircell S.L Pipeline Products & Ongoing Clinical Trials Overview 165
5.62 Wholehealth Products, Inc. Company Overview 170
5.62.1 Wholehealth Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview 170
5.63 Yale University Company Overview 171
5.63.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 171
5.64 Yeda Research and Development Company Ltd. Company Overview 172
5.64.1 Yeda Research and Development Company Ltd. Pipeline Products & Ongoing Clinical Trials Overview 172
6 Infectious Diagnostics Rapid & Point of Care Tests- Recent Developments 174
7 Appendix 210
7.1 Methodology 210
7.2 About GlobalData 212
7.3 Contact Us 213
7.4 Disclaimer 213


【レポート販売概要】

■ タイトル:世界における感染症迅速/POC検査製品のパイプライン動向2015
■ 英文:Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Review, 2015
■ 発行日:2015年10月1日
■ 調査会社:GlobalData
■ 商品コード:GDME0084EPD
■ 調査対象地域:グローバル
  • Petroglobe Inc.:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013
    Petroglobe Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Petroglobe Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key ope …
  • Campylobacter:医療検査市場2014
    The report presents a detailed analysis of the Campylobacter diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Campylobacter definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:     - Hospitals    &nbs …
  • 真空断熱パネルの世界市場予測(~2021)
    MarketsandMarkets projects that the market for vacuum insulation panels will grow from USD 6.38 Billion in 2016 to USD 8.14 Billion by 2021, at a CAGR of 4.99%. The market for vacuum insulation panels is growing due to innovative developments in the industrial sectors and growth in the construction and consumer durables industries. Rising per capita income of the middle class has increased its pur …
  • Transcatheter Heart Valve Market Outlook, 2013 – Approval of Second Generation Prosthetics and Increasing Surgeons’ Confidence and Proficiency to Drive TAVR Procedure Volumes
    Transcatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing Surgeons’ Confidence and Proficiency to Drive TAVR Procedure Volumes Summary GBI Research’s “Transcatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing Surgeons’ Confidence and Proficiency to Drive TAVR Procedure Volumes” report examines the marke …
  • エレクトロポレーション機器の世界市場2020-2024
    Global Electroporation Instruments Market 2020-2024 Technavio has been monitoring the global electroporation instruments market and it is poised to grow by USD 72.67 mn during 2020-2024, progressing at a CAGR of 7% during the forecast period. Our reports on electroporation instruments market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as …
  • ライムボレリア症ワクチンのグローバル市場機会分析(MarketVIEW: Lyme Borreliosis vaccines)
    Lyme Borreliosis (LB) or Lyme disease is caused by an infection with the bacterial spirochete Borrelia genospecies. The pathogen is transmitted to humans through the bite of infected Ixodes tick species. LB, which is endemic is large areas of Europe and North America, can cause a wide range of disease symptoms which range from a mild treatable rash to serious complications of the neurological syst …
  • 男性用化粧用品・洗面用品の世界市場2016-2020
    About the Male Toiletries Market In the global male toiletries market, vendors are innovating to deliver specialist products that offer multiple benefits and are tailor-made to suit the specific requirements of men. Companies have introduced different premium skin care and hair care products in their portfolios to target the affluent class. Deodorants have shown exponential growth in the market, a …
  • 顧客経験管理(CEM)の世界市場予測(~2021)
    The global customer experience management market is expected to grow from USD 5.06 Billion in 2016 to USD 13.18 Billion by 2021, at a CAGR of 21.1% during the forecast period. The primary drivers for the CEM market include increasing need to manage customer experience throughout the customer journey, need of retaining customers, providing competitive differentiation, and increasing e-commerce and …
  • スマートグリッド用センサーの世界市場
    About Smart Grid SensorsSmart grid sensors are compact electrical devices used for detecting and monitoring power system equipment. They track the power line temperatures and weather conditions around the power cables, and are also used to calculate the current carrying capacity of transmission lines. Technavio’s analysts forecast the global Smart Grid Sensors market to grow at a CAGR of 15.28% du …
  • Gliosarcoma:グローバル臨床試験レビューH2, 2013
    Gliosarcoma Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Gliosarcoma Global Clinical Trials Review, H2, 2013" provides data on the Gliosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gliosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of …
  • 自動車NVH(騒音・振動・ハーシュネス)材料の世界市場2017-2021:ポリウレタン、混紡繊維、 繊維ガラス、ポリエステル繊維、ニトリルブタジエンゴム(NBR)、ポリプロピレン、PVC、合成繊維、綿織物
    About Automotive NVH Materials Automotive NVH materials reduce unwanted noise, vibrations (oscillations due to automobile mechanics), and harshness (the level of discomfort) (NVH) in automobiles. Noise in vehicles may be caused by the engine, road, brakes, exhaust system, cooling fans, and external wind noise. Automotive NVH materials perform either acoustic absorption or acoustic insulation funct …
  • 弓道具の世界市場2016-2020
    About Archery Equipment Market The global archery equipment market is growing across the globe. In 2015, North America led the market with a 38.04% market share. It was followed by Europe and APAC. The market generated its revenue from the sale of different archery equipment. In 2015, North America dominated the global archery equipment market. This trend is expected to continue during the forecas …
  • グローバルにおけるスマートグリッド市場動向:March 2014
    Smart Grid Review - March 2014 Summary A substantial number of smart grid developments took place in February 2014, including product launches, fundraising events and the announcement and completion of contracts and projects. Four major acquisitions took place in February, including the acquisition of Dublin-based Activation Energy, which offers demand response software services in Ireland, by Ene …
  • イオン交換樹脂の世界市場:陽イオン交換樹脂、陰イオン交換樹脂、キレート樹脂、吸水性樹脂
    The ion exchange resins market size in terms of value is projected to grow at a CAGR of 5.82% between 2014 and 2019 to reach $2034.64 million by 2019. Asia-Pacific held the largest share in ion exchange resins market in 2013. Major growth in the Asia-Pacific region is expected from the water & wastewater treatment application. The ion exchange resins market in Asia-Pacific is growing fast, mainly …
  • バスケットボール用品の世界市場2016-2020:バスケットボールシューズ、バスケット用ボール、バスケットボール用アクセサリ、バスケットボール練習器具
    About Basketball Equipment The basketball shoe segment is witnessing a significant prominence over all other product segments. It accounts for the largest portion of the overall sales revenue and has a dominant share in the market. This is expected to gain further traction during the forecast period as the adoption of basketball footwear is high among the global populace. Regions like North Americ …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。